Failure to report protocol violations in clinical trials: a threat to internal validity?
Open Access
- 28 September 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Trials
- Vol. 12 (1), 214
- https://doi.org/10.1186/1745-6215-12-214
Abstract
Excessive protocol violations (PV), which can be defined as preventable mistakes in study conduct, may result in patient harm and introduce errors into a clinical trial's results leading to flawed trial conclusions.This publication has 24 references indexed in Scilit:
- A systematic review of techniques and interventions for improving adherence to inclusion and exclusion criteria during enrolment into randomised controlled trialsTrials, 2010
- Feasibility study to inform the design of a randomised controlled trial to eradicate Pseudomonas aeruginosa infection in individuals with Cystic FibrosisTrials, 2010
- Tutorial Reduces Protocol Deviations in Multicenter ACTG Trials with Pharmacology EndpointsHIV Research & Clinical Practice, 2006
- Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical surveyBMJ, 2005
- A Review of the True Methodological Quality of Nutritional Support Trials Conducted in the Critically Ill: Time for ImprovementAnesthesia & Analgesia, 2005
- Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical PracticeStroke, 2003
- Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problemsStatistics in Medicine, 2002
- International sepsis trial (INTERSEPT)Critical Care Medicine, 1996